Human IL-1α(Interleukin 1 Alpha) ELISA Kit
中文名称:人白介素1α(IL-1α)酶联免疫吸附测定试剂盒
别称:
IL1A、IL1-A、IL1、IL1F1、Preinterleukin 1 Alpha、Hematopoietin-1、Pro-Interleukin-1-Alpha
Price:
Size:
96T
48T
96T*5
- 反应性: Human
- 检测范围: 3.91-250 pg/mL
- 灵敏度: 2.35 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人IL-1α抗体包被于酶标板上,实验时样品(或标准品)中的人IL-1α会与包被抗体结合。后依次加入生物素化的抗人IL-1α抗体和辣根过氧化物酶标记的亲和素,抗人IL-1α抗体与结合在包被抗体上的人IL-1α结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,IL-1α浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中IL-1α的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96T
/ 48T
/ 96T*5
|
反应时间 | 3.5h |
反应性 | Human |
检测方法 | Colormetric |
检测范围 | 3.91-250 pg/mL |
灵敏度 | 2.35 pg/mL |
样本体积 | 100μL |
样本类型 | 血浆,细胞上清,细胞提取液体,组织匀浆等其他生物体液 |
特异性 | 可检测样本中的人IL-1α,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Overcoming the Heat Endurance of Tumor Cells by Interfering with the Anaerobic Glycolysis Metabolism for Improved Photothermal Therapy
IF: 13.942Journal:ACS Nano -
A SCID mouse-human lung xenograft model of SARS-CoV-2 infection
IF: 11.556 -
Cytokine physiognomies of MSCs from varied sources confirm the regenerative commitment post-coculture with activated neutrophils
IF: 5.546 -
Ultrasensitive detection of interleukin 1α using 3-phosphonopropionic acid modified FTO surface as an effective platform for disposable biosensor fabrication
IF: 4.722 -
Inflammation-dependent ISG15 upregulation mediates MIA-induced dendrite damages and depression by disrupting NEDD4/Rap2A signaling
IF: 4.328Journal:BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASEPMID:30826466 -
Study on the Mechanism of Improving HIV/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation
IF: 4.319 -
Exploring the Anti-Acne Potential of Impepho [Helichrysum odoratissimum (L.) Sweet] to Combat Cutibacterium acnes Virulence
IF: 4.225Journal:Frontiers in Pharmacology -
Sapylin (OK-432) alters inflammation and angiogenesis in vivo and vitro
IF: 3.743 -
The lncRNA MALAT1 protects the endothelium against ox‐LDL‐induced dysfunction via upregulating the expression of the miR‐22‐3p target genes CXCR2 and AKT
IF: 3.169Journal:FEBS LETTERS -
Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis
IF: 2.688Journal:BMC INFECTIOUS DISEASES